Amgen Correlations
AMGN Stock | USD 316.91 2.31 0.72% |
The current 90-days correlation between Amgen Inc and Merck Company is 0.09 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Amgen Correlation With Market
Poor diversification
The correlation between Amgen Inc and DJI is 0.61 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and DJI in the same portfolio, assuming nothing else is changed.
Amgen |
Moving together with Amgen Stock
0.7 | MRK | Merck Company Sell-off Trend | PairCorr |
0.67 | INZY | Inozyme Pharma | PairCorr |
0.62 | KRYS | Krystal Biotech | PairCorr |
0.64 | REGN | Regeneron Pharmaceuticals | PairCorr |
Moving against Amgen Stock
0.47 | GNFT | Genfit | PairCorr |
0.42 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.46 | RNAC | Cartesian Therapeutics Symbol Change | PairCorr |
0.44 | LPCN | Lipocine | PairCorr |
0.42 | RVMD | Revolution Medicines | PairCorr |
0.34 | BGNE | BeiGene | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Amgen Stock performing well and Amgen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Amgen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
MRK | 0.83 | (0.21) | 0.00 | (0.48) | 0.00 | 1.61 | 4.89 | |||
ABBV | 0.79 | 0.06 | 0.03 | 0.20 | 0.86 | 1.53 | 6.52 | |||
GILD | 0.77 | 0.21 | 0.16 | 0.50 | 0.76 | 2.16 | 4.75 | |||
JNJ | 0.60 | (0.08) | 0.00 | (0.15) | 0.00 | 1.09 | 3.25 | |||
BMY | 1.18 | 0.19 | 0.11 | 0.59 | 1.19 | 2.08 | 8.51 | |||
PFE | 0.87 | (0.19) | 0.00 | (0.22) | 0.00 | 2.17 | 6.28 | |||
LLY | 1.35 | (0.08) | (0.03) | 0.01 | 1.83 | 2.68 | 15.76 | |||
BIIB | 1.02 | (0.33) | 0.00 | (0.24) | 0.00 | 2.02 | 6.36 |
Amgen Corporate Management
Linda Louie | VP Officer | Profile | |
James MD | Executive Officer | Profile | |
Nancy Grygiel | Senior Officer | Profile | |
Justin Claeys | Vice Relations | Profile |